Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The oral version delivers less weight loss than the injection (expected, given lower bioavailability), but still clinically meaningful especially for patients who would never self-inject
(8 March 2023)
Originally developed by Metabolic Pharmaceuticals in Australia during the 1990s, this synthetic peptide was designed to harness growth hormones fat-mobilizing properties while avoiding the metabolic complications associated with full-length GH therapy
Reserve these for rescue use, not daily maintenance
US$ 27.53
US$ 25.60
US$ 24.15
US$ 28.13
US$ 21.71
US$ 22.96
US$ 20.46
US$ 20.96
US$ 25.89
US$ 26.43
US$ 26.02
